Volume 84 Issue 38 | p. 29 | Insights
Issue Date: September 18, 2006

Rough Ride For Stem Cell Research

Embryonic stem cell scientists are on roller coaster of funding, research highs and lows
Department: Government & Policy | Collection: Stem Cells, Stimulus Funding

Late last month, researchers from the biotechnology company Advanced Cell Technology (ACT) published a paper in Nature indicating that they had derived embryonic stem cell lines from human embryos without destroying the embryos (C&EN, Aug. 28, page 10). The work was significant because it appeared to remove a major ethical roadblock to stem cell research, namely that an embryo must be sacrificed to develop stem cell lines that have the potential to treat . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society